BIIB earnings
Biogen (BIIB) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
BIIB earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | 2.62 | 1.99 | 31.66% | $2.80B |
| Q2 2026 | Jul 29, 2026 | 3.60 | 2.94 | 22.45% | $2.74B |
| Q1 2026 | Apr 29, 2026 | 3.57 | 3.05 | 17.05% | $2.48B |
| Q4 2025 | Feb 6, 2026 | 1.99 | 1.63 | 22.09% | $2.28B |
| Q3 2025 | Oct 30, 2025 | 4.81 | 3.88 | 23.97% | $2.45B |
| Q2 2025 | Jul 31, 2025 | 5.47 | 3.90 | 40.26% | $2.65B |
| Q1 2025 | May 1, 2025 | 3.02 | 2.90 | 4.14% | $2.43B |
| Q4 2024 | Feb 12, 2025 | 3.44 | 3.43 | 0.29% | $2.45B |
| Q3 2024 | Oct 30, 2024 | 4.08 | 3.77 | 8.22% | $2.47B |
| Q2 2024 | Aug 1, 2024 | 5.28 | 4.07 | 29.73% | $2.46B |
| Q1 2024 | Apr 24, 2024 | 3.67 | 3.47 | 5.76% | $2.29B |
| Q4 2023 | Feb 13, 2024 | 2.95 | 3.16 | -6.65% | $2.39B |
| Nov 8, 2023 | 4.36 | 3.99 | 9.27% | – | |
| Jul 25, 2023 | 4.02 | 3.77 | 6.63% | – | |
| Apr 25, 2023 | 3.40 | 3.28 | 3.66% | – | |
| Feb 15, 2023 | 4.05 | 3.48 | 16.38% | – | |
| Oct 25, 2022 | 4.77 | 4.13 | 15.50% | – | |
| Jul 20, 2022 | 5.25 | 4.06 | 29.31% | – | |
| May 3, 2022 | 3.62 | 4.41 | -17.91% | – | |
| Feb 3, 2022 | 3.39 | 3.32 | 2.11% | – |
- BIIB reports next on Feb 5, 2027, with EPS of 3.29 expected.
- BIIB beat EPS estimates in 112 of its last 136 reports.
Updated 2026-11-03 01:05 UTC